FDA: Hospira recalls one lot of Vancomycin Hydrochloride for Injection

Editor's Note

The Food and Drug Administration (FDA) on January 25 announced the recall by Hospira, Inc (Lake Forest, Illinois) of one lot of Vancomycin Hydrochloride for Injection, (USP (NDC: 0409-6510-01, Lot 591053A, Expiry Date 1NOV2017).

The recall was initiated because of a confirmed customer report of the presence of particulate matter in a single vial.

The lot was distributed from August 2016 through September 2016.

Posted 01/25/2017] AUDIENCE: Pharmacy ISSUE: Hospira, Inc. is voluntarily recalling one lot of Vancomycin Hydrochloride for Injection, USP (NDC: 0409-6510-01, Lot 591053A, Expiry Date 1NOV2017), to the hospital/retail level due to a confirmed customer report for the presence of particulate matter within a single vial.